Literature DB >> 25125421

A validation study of the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) in Chinese older adults in Hong Kong.

P Y Yeung1, L L Wong2, C C Chan3, Jess L M Leung2, C Y Yung3.   

Abstract

OBJECTIVE: To validate the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) in identification of mild cognitive impairment and dementia in Chinese older adults.
DESIGN: Cross-sectional study.
SETTING: Cognition clinic and memory clinic of a public hospital in Hong Kong. PARTICIPANTS: A total of 272 participants (dementia, n=130; mild cognitive impairment, n=93; normal controls, n=49) aged 60 years or above were assessed using HK-MoCA. The HK-MoCA scores were validated against expert diagnosis according to the Diagnostic and Statistical Manual of Mental Disorders (4th ed) criteria for dementia and Petersen's criteria for mild cognitive impairment. Statistical analysis was performed using receiver operating characteristic curve and regression analyses. Additionally, comparison was made with the Cantonese version of Mini-Mental State Examination and Global Deterioration Scale.
RESULTS: The optimal cutoff score for the HK-MoCA to differentiate cognitive impaired persons (mild cognitive impairment and dementia) from normal controls was 21/22 after adjustment of education level, giving a sensitivity of 0.928, specificity of 0.735, and area under the curve of 0.920. Moreover, the cutoff to detect mild cognitive impairment was 21/22 with a sensitivity of 0.828, specificity of 0.735, and area under the curve of 0.847. Score of the Cantonese version of the Mini-Mental State Examination to detect mild cognitive impairment was 26/27 with a sensitivity of 0.785, specificity of 0.816, and area under the curve of 0.857. At the optimal cutoff of 18/19, HK-MoCA identified dementia from controls with a sensitivity of 0.923, specificity of 0.918, and area under the curve of 0.971.
CONCLUSION: The HK-MoCA is a useful cognitive screening instrument for use in Chinese older adults in Hong Kong. A score of less than 22 should prompt further diagnostic assessment. It has comparable sensitivity with the Cantonese version of Mini-Mental State Examination for detection of mild cognitive impairment. It is brief and feasible to conduct in the clinical setting, and can be completed in less than 15 minutes. Thus, HK-MoCA provides an attractive alternative screening instrument to Mini-Mental State Examination which has ceiling effect (ie may fail to detect mild/moderate cognitive impairment in people with high education level or premorbid intelligence) and needs to be purchased due to copyright issues.

Entities:  

Keywords:  Cognition disorders; Hong Kong; Sensitivity and specificity

Mesh:

Year:  2014        PMID: 25125421     DOI: 10.12809/hkmj144219

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  32 in total

1.  Eye-movement patterns in face recognition are associated with cognitive decline in older adults.

Authors:  Cynthia Y H Chan; Antoni B Chan; Tatia M C Lee; Janet H Hsiao
Journal:  Psychon Bull Rev       Date:  2018-12

2.  Patterns of Physical Activity and Sedentary Behavior for Older Adults with Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Normal in Hong Kong.

Authors:  Zhihui Lu; Tamara B Harris; Eric J Shiroma; Jason Leung; Timothy Kwok
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Montreal cognitive assessment (MoCA) is highly correlated with 1-year mortality in hip fracture patients.

Authors:  R M Y Wong; R W K Ng; W W Chau; W H Liu; S K H Chow; C Y Tso; N Tang; W-H Cheung
Journal:  Osteoporos Int       Date:  2022-06-28       Impact factor: 5.071

4.  Tai Chi versus conventional exercise for improving cognitive function in older adults: a pilot randomized controlled trial.

Authors:  Angus P Yu; Edwin C Chin; Danny J Yu; Daniel Y Fong; Calvin P Cheng; Xiaoqing Hu; Gao X Wei; Parco M Siu
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

5.  Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study.

Authors:  Pan Li; Yu-Ying Zhou; Da Lu; Yan Wang; Hui-Hong Zhang
Journal:  Neurol Sci       Date:  2015-11-14       Impact factor: 3.307

6.  Feasibility, Acceptability, and Efficacy of Virtual Reality Training for Older Adults and People With Disabilities: Single-Arm Pre-Post Study.

Authors:  Pui Hing Chau; Yan Yan Jojo Kwok; Mee Kie Maggie Chan; Ka Yu Daniel Kwan; Kam Lun Wong; Ying Ho Tang; Kan Lung Peter Chau; Sheung Wa Matthew Lau; Yan Yan Yannex Yiu; Mei Yan Fanny Kwong; Wai Ting Thomas Lai; Mun Kit Leung
Journal:  J Med Internet Res       Date:  2021-05-04       Impact factor: 5.428

7.  Handgrip strength but not SARC-F score predicts cognitive impairment in older adults with multimorbidity in primary care: a cohort study.

Authors:  Paul Kwok Ming Poon; King Wa Tam; Dexing Zhang; Benjamin Hon Kei Yip; Jean Woo; Samuel Yeung Shan Wong
Journal:  BMC Geriatr       Date:  2022-04-19       Impact factor: 4.070

8.  Preliminary findings on the reliability and validity of the Cantonese Birmingham Cognitive Screen in patients with acute ischemic stroke.

Authors:  Xiaoping Pan; Haobo Chen; Wai-Ling Bickerton; Johnny King Lam Lau; Anthony Pak Hin Kong; Pia Rotshtein; Aihua Guo; Jianxi Hu; Glyn W Humphreys
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-16       Impact factor: 2.570

9.  Improved predictive ability of the Montreal Cognitive Assessment for diagnosing dementia in a community-based study.

Authors:  Jung-Lung Hsu; Yen-Chun Fan; Ya-Li Huang; Jui Wang; Wei-Hung Chen; Hou-Chang Chiu; Chyi-Huey Bai
Journal:  Alzheimers Res Ther       Date:  2015-11-09       Impact factor: 6.982

10.  Neural Correlates of Motor Recovery after Robot-Assisted Training in Chronic Stroke: A Multimodal Neuroimaging Study.

Authors:  Cheng Chen; Kai Yuan; Xin Wang; Ahsan Khan; Winnie Chiu-Wing Chu; Raymond Kai-Yu Tong
Journal:  Neural Plast       Date:  2021-06-09       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.